2024 annual financial data
Wave Life Sciences 2024 Operating margin
Direct answer
Operating margin was -101.94%.
Operating income was -110,403,000 USD and net income was -97,008,000 USD.
Operating cash flow was -151,026,000 USD.
Get free Wave Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 108,302,000 USD
- Operating income
- -110,403,000 USD
- Net income
- -97,008,000 USD
- Operating cash flow
- -151,026,000 USD